EYE
Overvalued by 21.6% based on the discounted cash flow analysis.
Market cap | $1.38 Billion |
---|---|
Enterprise Value | $1.69 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.84 |
Beta | 1.6 |
Outstanding Shares | 78,312,620 |
Avg 30 Day Volume | 1,021,094 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -20.88 |
---|---|
PEG | -28.75 |
Price to Sales | 0.65 |
Price to Book Ratio | 1.76 |
Enterprise Value to Revenue | 0.79 |
Enterprise Value to EBIT | 47.63 |
Enterprise Value to Net Income | -26 |
Total Debt to Enterprise | 0.27 |
Debt to Equity | 0.56 |
No data
No data